Meyer-Lindenberg, Hannah
Moessnang, Carolin
Oakley, Bethany
Ahmad, Jumana
Mason, Luke
Jones, Emily J. H.
Hayward, Hannah L.
Cooke, Jennifer
Crawley, Daisy
Holt, Rosemary
Tillmann, Julian
Charman, Tony
Baron-Cohen, Simon
Banaschewski, Tobias
Beckmann, Christian
Tost, Heike
Meyer-Lindenberg, Andreas
Buitelaar, Jan K.
Murphy, Declan G.
Brammer, Michael J.
Loth, Eva
Funding for this research was provided by:
Innovative Health Initiative (115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394, 115300, 777394)
Article History
Received: 10 April 2022
Accepted: 31 August 2022
First Online: 10 November 2022
Declarations
:
: The study was approved by the local ethical committees of the participating centres, and written informed consent was obtained from all participants. For minors or those without capacity to consent, ethics consent was obtained from a parent or guardian. KCL, UCAM: London Queen Square Health Research, Authority Research Ethics Committee (ID/reference number: 13/LO/1156). RUNMC, UMCU: Instituut Waarborging Kwaliteit en Veiligheid, Commissie Mensgebonden Onderzoek, Regio Arnhem-Nijmegen (Radboud University Medical Centre Institute Ensuring, Quality and Safety Committee on Research Involving Human Subjects Arnhem-Nijmegen) (ID/reference number: 2013/455). CIMH: UMM Universitatsmedizin Mannheim, Medizinische Ethik Commission II (UMM University Medical Mannheim, Medical Ethics Commission II) (ID/reference number: 2014-540 N-MA). UCBM: Università Campus Bio-Medico di Roma, Comitato Etico (University Campus Bio-Medical Ethics Committee of Rome) (ID/reference number: 18/14 PAR ComET CBM).
: Not applicable.
: JT is a paid consultant to F. Hoffmann-La Roche Ltd. TC has served as a paid consultant to F. Hoffmann-La Roche Ltd. and Servier and has received royalties from Sage Publications and Guilford Publications. TB served in an advisory or consultancy role for Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Takeda, and Infectopharm. He received conference support or speaker’s fee by Lilly, Medice, and Takeda. He received royalties from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press; the present work is unrelated to these relationships. AM-L has received consultant fees in the past two years from Boehringer Ingelheim, Elsevier, Lundbeck Int. Neuroscience Foundation, Lundbeck AS, The Wolfson Foundation, Thieme Verlag, Sage Therapeutics, von Behring Stiftung, Fondation FondaMental, Janssen-Cilag GmbH, MedinCell, Brain Mind Institute, CISSN. Furthermore, he has received speaker fees from Italian Society of biological Psychiatry, Merz-Stiftung, Forum Werkstatt Karlsruhe, Lundbeck SAS France, BAG Psychiatrie Oberbayern. JB has been in the past 3 years a consultant to/member of advisory board of/and/or speaker for Takeda/Shire, Roche, Medice, Angelini, Janssen, and Servier. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, royalties. EL is an Associate Editor at Molecular Autism. DM has been paid for advisory board work by F. Hoffmann-La Roche Ltd. and Servier, and for editorial work by Springer. The other authors declare that they have no competing interests.